RecruitingNCT04185844

American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)


Sponsor

University of New Mexico

Enrollment

500 participants

Start Date

Aug 31, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Despite many advances in our understanding of the natural history and progression of chronic kidney disease (CKD) and cardio vascular disease (CVD) in the parent CRIC study over the past 15 years, important questions about key risk factors for these diseases remain unanswered in the AI population. To address this burden of CKD in AI communities Investigators formed a consortium of investigators with extensive experience in conducting research of chronic diseases including diabetes, cardiovascular and kidney disease in AIs of Southwestern US. The proposed CRIC ancillary cohort study of 500 AIs (AI-CRIC) will rapidly improve our understanding of both potential risk factors for CKD progression, as well as the scope of this disease among AIs. This study leverages the current CRIC study and incorporates the planned activities of the next phase of the study - "CRIC 2018" - by implementing contemporary CRIC protocols for kidney and cardiovascular measurement and outcomes.


Eligibility

Min Age: 21 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is tracking the progression of kidney disease in American Indian people who have early-to-moderate chronic kidney disease (CKD). The goal is to understand how kidney disease develops and progresses in this population, which has a disproportionately high burden of kidney failure. **You may be eligible if...** - You are an American Indian person - Your kidney filtration rate (eGFR) is between 61–79 with protein in the urine, OR your eGFR is 60 or below regardless of protein levels **You may NOT be eligible if...** - You are unwilling or unable to give consent - You have a life expectancy of less than 3 years - You are already on dialysis or have had a kidney transplant - You have kidney cancer, myeloma, polycystic kidney disease, or are immunosuppressed Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

NIDDK-Phoenix Epidemiology and Clinical Research

Phoenix, Arizona, United States

First Nations Community Health Source

Albuquerque, New Mexico, United States

Zuni Health Initiative Center

Black Rock, New Mexico, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04185844


Related Trials